ArticleNature and science of sleep2025
Artificial Intelligence Screening Tool for Obstructive Sleep Apnoea: A Study Based on Outpatients at a Sleep Medical Centre.
Article in Nature and science of sleep, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Advancements, challenges, and prospects of explainable AI in sleep disordered breathing.Sleep & breathing = Schlaf & Atmung · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Due to the lack of clear screening guidelines for different populations, identify strategies for obstructive sleep apnea (OSA) in the outpatient population are unclear, a large number of potential OSA outpatients have not been identified in time. The purpose of our study was to evaluate the applicability and accuracy of artificial intelligence sleep screening in outpatients and to provide a reference for OSA screening in different populations. Methods: A type IV wearable artificial intelligence sleep monitoring (AISM) device was used to screen adults in the sleep clinic of the Sleep Medical Center for OSA screening, and the general demographic data of the patients were collected. The epidemiological characteristics obtained by AISM screening were analysed. The accuracy of the AISM for the diagnosis of OSA was evaluated and compared with that of polysomnography (PSG). Results: A total of 1492 participants completed all the studies. The data included 1448 cases total, including 1096 male patients and 352 female patients, with 620 of the total patients being overweight (42.82%) and 429 being obese patients (29.63%). The prevalence of males was 78.19%, and that of females was 55.97% (χ2 = 95.72, P < 0.001). In males, the risk of moderate to severe OSA was 74.21% in obese people, while in females, the risk was 50%. Age, body mass index (BMI) and the oxygen desaturation index (ODI) were positively correlated and negatively correlated with the lowest and mean oxygen saturation. A total of 100 participants completed both PSG and AISM monitoring, and the accuracies of the AISM in diagnosing mild and moderate-to-severe OSA were 94% and 98%, respectively. Conclusion: The AISM exhibits good accuracy, and the use of an objective and convenient sleep detection device to screen a large sample population of outpatients is feasible. The prevalence of OSA in adults in sleep clinics is high, and age, sex, and BMI are risk factors for OSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.